KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Exchange Rate Effect: 2013-2024

Historic Exchange Rate Effect for Biomarin Pharmaceutical (BMRN) over the last 12 years, with Dec 2024 value amounting to $4.8 million.

  • Biomarin Pharmaceutical's Exchange Rate Effect rose 125.47% to $739,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year increase of 6.43%. This contributed to the annual value of $4.8 million for FY2024, which is 269.27% up from last year.
  • Latest data reveals that Biomarin Pharmaceutical reported Exchange Rate Effect of $4.8 million as of FY2024, which was up 269.27% from $1.3 million recorded in FY2023.
  • Biomarin Pharmaceutical's 5-year Exchange Rate Effect high stood at $4.8 million for FY2024, and its period low was -$1.1 million during FY2020.
  • Over the past 3 years, Biomarin Pharmaceutical's median Exchange Rate Effect value was $1.3 million (recorded in 2023), while the average stood at $2.1 million.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first crashed by 227.49% in 2020, then surged by 3,987.50% in 2023.
  • Over the past 5 years, Biomarin Pharmaceutical's Exchange Rate Effect (Yearly) stood at -$1.1 million in 2020, then soared by 95.04% to -$57,000 in 2021, then spiked by 156.14% to $32,000 in 2022, then skyrocketed by 3,987.50% to $1.3 million in 2023, then soared by 269.27% to $4.8 million in 2024.